Cover Image

Clinical Relapse Versus Treatment Failure: The Case for Surveillance for Re‐Appearance of Minimal Measurable Disease in Pediatric Patients with Higher Risk B‐ALL

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Paul S. Gaynon, Linwei Li
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pediatric Blood & Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Microphotopheresis for the Treatment of Graft‐Versus‐Host Disease in Pediatric Patients
by: Irina Kumukova, et al.
Published: (2025)

Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
by: Marko Kavcic, et al.
Published: (2025)

Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis
by: Wenqian Wang, et al.
Published: (2026)

Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre‐ and Post‐Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment Failure
by: Andrew Muskara, et al.
Published: (2025)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
by: Andrew E. Place, et al.
Published: (2025)

Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma
by: Stephanie Fetzko, et al.
Published: (2024)

Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study
by: Daniel A. Morgenstern, et al.
Published: (2026)

Sensitivity and Specificity of a Signaling Question for Surveillance of Cognitive Functioning in Pediatric Sickle Cell Disease
by: Steven J. Hardy, et al.
Published: (2025)

Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma”
Published: (2025)

Focal Nodular Hyperplasia (FNH)/FNH‐Like Lesions: An Important Potential Mimic of Relapsed Malignancy in Pediatric Cancer Patients
by: Jonathan Abrams, et al.
Published: (2025)

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose
by: Jonathan D. Bender, et al.
Published: (2026)

Circulating Tumor DNA in Pediatric Mature B‐Cell Non‐Hodgkin Lymphoma for Genotyping and Minimal Disease Monitoring
by: Jana Werner, et al.
Published: (2025)

Post‐Transplant Cyclophosphamide for Graft‐Versus‐Host Disease Prophylaxis in Pediatric Stem Cell Transplantation
by: Aaron E. Fan, et al.
Published: (2025)

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse
by: Vicente Santa‐Maria Lopez, et al.
Published: (2026)

Intestinal Low‐Dose Radiation to Overcome PD‐1 Resistance in Pediatric Relapsed/Refractory Hodgkin Lymphoma
by: Shubham Sahni, et al.
Published: (2026)

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort
by: Maria Debora De Pasquale, et al.
Published: (2026)

Risk‐Stratified Phase II Clinical Trial for Epstein–Barr Virus‐Associated Hemophagocytic Lymphohistiocytosis in Pediatric, Adolescent, and Young Adult Patients in Japan
by: Kenichi Sakamoto, et al.
Published: (2025)

Novel Genetic Risk Factor Identified for L‐Asparaginase‐Induced Pancreatitis in Pediatric Patients With Cancer
by: Edward J. Raack, et al.
Published: (2026)

Standard‐Dose Versus High‐Dose Cisplatin for Intermediate/Poor‐Risk Extracranial Malignant Germ Cell Tumors: Re‐Analysis of Pediatric Oncology Group 9049 and Children's Cancer Group 8882 Trial Using Updated MaGIC Risk Stratification
by: Daniel Prior, et al.
Published: (2025)

Clinical and Genetic Characteristics of Pediatric Colorectal Cancer
by: Qiyang Shen, et al.
Published: (2025)

Systemic Inflammatory Response Post Alemtuzumab and Low‐Dose Total Body Irradiation in Pediatric Patients With Sickle Cell Disease: A Case Series
by: Rozalyn Chok, et al.
Published: (2024)

Correction to “Outcomes of Relapsed Favorable‐Histology Wilms Tumor in Non‐Clinical Trial Setting”
Published: (2025)

Dual KMT2A::USP2 and CBL::GRIK4 Fusions in Infant‐Type B‐ALL: A Case Report
by: ChengKan Du, et al.
Published: (2025)

Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma
by: Molly Mack, et al.
Published: (2026)

The Threat of Medical Misinformation: A Case of Ivermectin Toxicity in a Pediatric Oncology Patient
by: Stephen Gilene, et al.
Published: (2025)

Treatment Strategies and Outcomes in Pediatric Patients With Immune Thrombocytopenia Undergoing Surgical Procedures: A Multicenter Study
by: Matthew Ross, et al.
Published: (2026)

Sustained Remission of Relapsed Extranodal NK/T‐Cell Lymphoma After Treatment With Camrelizumab Plus P‐GEMOX and Autologous Stem Cell Transplantation: A Case Report
by: Kun Yang, et al.
Published: (2024)

Syndecan‐1 is Associated With Sinusoidal Obstruction Syndrome and Severe Acute Graft‐Versus‐Host Disease After Pediatric Hematopoietic Stem Cell Transplantation
by: Denise Elbæk Horan, et al.
Published: (2025)

A Rare Case of Pediatric BRAF V600E‐Mutated Erdheim–Chester Disease With Isolated Central Nervous System Onset: Diagnosis, Treatment, and Efficacy Evaluation
by: Jing Ni, et al.
Published: (2026)

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
by: Ava Momm, et al.
Published: (2026)

Clinical Characteristics and Prognostic Risk Factors for Pediatric B‐Cell Lymphoblastic Lymphoma: A Multicenter Retrospective Cohort Study for China Net Childhood Lymphoma
by: Zhijuan Liu, et al.
Published: (2026)

Socioeconomic Status and Stroke Risk in Pediatric Sickle Cell Disease: A DISPLACE Study Secondary Analysis
by: Jeffrey G. Edwards, et al.
Published: (2025)

Treatment Experience Using a Micro‐Induction Buprenorphine Protocol for Chronic Pain in Pediatric Sickle Cell Disease
by: Ashwin Patel, et al.
Published: (2025)

Novel Treatment of Yttrium‐90 Radioembolization‐Induced Liver Disease With Defibrotide in a Pediatric Liver Transplant Recipient
by: Elise Kang, et al.
Published: (2025)

CIC ‐Rearranged Sarcomas With Unusual Morphology and Molecular Features: A Case Series of Pediatric Patients
by: Lianyuan Yu, et al.
Published: (2026)

Baseline Neurocognitive Functioning Among Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana Farber Cancer Institute ALL Consortium Study 16‐001
by: Sameera Ramjan, et al.
Published: (2025)

Progressive Transformation of Germinal Centers Mimicking Metastatic Nodal Disease in a Pediatric Patient With Synovial Sarcoma
by: Hutton Chapman, et al.
Published: (2025)

Preemptive Versus Empirical Antifungal Therapy for High‐Risk, Febrile, Neutropenic Solid Tumor Patients in an LMIC Setting
by: Omnia Al‐Qadi, et al.
Published: (2025)

Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives
by: Kathryn S. Sutton, et al.
Published: (2025)

Adenovirus Outbreak in Pediatric Cancer Patients
by: Swati Bhayana, et al.
Published: (2025)